Building a patient database and blood biobank for bile duct and gallbladder tumors
Part of Cancer, Digestive system clinical trials.
This study is collecting medical information and blood samples from people with bile duct or gallbladder tumors to build a database that can help doctors better understand these conditions and improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 74 years old.
- You have been diagnosed (or are suspected to have) a tumor in your bile ducts or gallbladder.
- You are able to care for yourself or need only occasional help (Karnofsky score over 50).
- You are willing to give blood samples and attend follow-up visits.
- You do not have serious heart, brain, kidney, or immune system conditions that would interfere.
- You are not pregnant or breastfeeding (if applicable).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information and blood samples from people with gallbladder cancer to build a database. It helps researchers learn more about the disease and may lead to better treatments in the future.
This study looks for new ways to measure cancer-related “biomarkers” (signals in blood or tumor samples) in people with bile duct cancer or gallbladder cancer. The goal is to improve how these cancers are identified and tracked, which could help doctors make better treatment decisions.
This trial is studying people with gallbladder cancer, abnormal cell changes (dysplasia), or gallstones. It aims to learn more about these conditions, possibly before or after treatment, or before gallbladder removal surgery.
This study looks at tumor tissue samples from people with bile duct or gallbladder cancer to find biomarkers (clues in the tumor) that might help guide future treatment. By studying these samples, researchers hope to understand more about these cancers and improve care.
This study looks at genetic and molecular patterns in people with bile duct or gallbladder cancers, and compares them with people without cancer (or with chronic liver disease). It may help researchers understand why these cancers happen and how to spot risk earlier.
This study looks at lab markers (including genetic tests) to predict how people with bile duct cancer respond to treatment. Your answers and samples may help doctors personalize care for bile duct cancer in the future.
Hear when a new Biliary Tract Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.